363 related articles for article (PubMed ID: 28292317)
1. The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysis.
Falk Delgado A; Falk Delgado A
Trials; 2017 Mar; 18(1):125. PubMed ID: 28292317
[TBL] [Abstract][Full Text] [Related]
2. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study.
Falk Delgado A; Falk Delgado A
Trials; 2017 Jul; 18(1):354. PubMed ID: 28747226
[TBL] [Abstract][Full Text] [Related]
3. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.
Ridker PM; Torres J
JAMA; 2006 May; 295(19):2270-4. PubMed ID: 16705108
[TBL] [Abstract][Full Text] [Related]
4. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
Als-Nielsen B; Chen W; Gluud C; Kjaergard LL
JAMA; 2003 Aug; 290(7):921-8. PubMed ID: 12928469
[TBL] [Abstract][Full Text] [Related]
5. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
[TBL] [Abstract][Full Text] [Related]
6. Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005.
Conen D; Torres J; Ridker PM
Circulation; 2008 Sep; 118(13):1321-7. PubMed ID: 18779441
[TBL] [Abstract][Full Text] [Related]
7. Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.
Khan NA; Lombeida JI; Singh M; Spencer HJ; Torralba KD
Arthritis Rheum; 2012 Jul; 64(7):2059-67. PubMed ID: 22275179
[TBL] [Abstract][Full Text] [Related]
8. Outcomes, Interventions and Funding in Randomised Research Published in High-Impact Journals.
Grey P; Grey A; Bolland MJ
Trials; 2018 Oct; 19(1):592. PubMed ID: 30373636
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance.
Hakoum MB; Jouni N; Abou-Jaoude EA; Hasbani DJ; Abou-Jaoude EA; Lopes LC; Khaldieh M; Hammoud MZ; Al-Gibbawi M; Anouti S; Guyatt G; Akl EA
BMJ Open; 2017 Oct; 7(10):e015997. PubMed ID: 28982811
[TBL] [Abstract][Full Text] [Related]
10. Industry-funded versus non-profit-funded critical care research: a meta-epidemiological overview.
Janiaud P; Cristea IA; Ioannidis JPA
Intensive Care Med; 2018 Oct; 44(10):1613-1627. PubMed ID: 30151688
[TBL] [Abstract][Full Text] [Related]
11. Funding source, trial outcome and reporting quality: are they related? Results of a pilot study.
Clifford TJ; Barrowman NJ; Moher D
BMC Health Serv Res; 2002 Sep; 2(1):18. PubMed ID: 12213183
[TBL] [Abstract][Full Text] [Related]
12. Association between research sponsorship and study outcome in plastic surgery literature.
Momeni A; Becker A; Bannasch H; Antes G; Blümle A; Stark GB
Ann Plast Surg; 2009 Dec; 63(6):661-4. PubMed ID: 19887933
[TBL] [Abstract][Full Text] [Related]
13. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I
Trials; 2011 Feb; 12():58. PubMed ID: 21356072
[TBL] [Abstract][Full Text] [Related]
14. Outcome switching in randomized controlled oncology trials reporting on surrogate endpoints: a cross-sectional analysis.
Falk Delgado A; Falk Delgado A
Sci Rep; 2017 Aug; 7(1):9206. PubMed ID: 28835682
[TBL] [Abstract][Full Text] [Related]
15. Is funding source related to study reporting quality in obesity or nutrition randomized control trials in top-tier medical journals?
Kaiser KA; Cofield SS; Fontaine KR; Glasser SP; Thabane L; Chu R; Ambrale S; Dwary AD; Kumar A; Nayyar G; Affuso O; Beasley M; Allison DB
Int J Obes (Lond); 2012 Jul; 36(7):977-81. PubMed ID: 22064159
[TBL] [Abstract][Full Text] [Related]
16. Sample size and number of outcome measures of veterinary randomised controlled trials of pharmaceutical interventions funded by different sources, a cross-sectional study.
Wareham KJ; Hyde RM; Grindlay D; Brennan ML; Dean RS
BMC Vet Res; 2017 Oct; 13(1):295. PubMed ID: 28978314
[TBL] [Abstract][Full Text] [Related]
17. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
[TBL] [Abstract][Full Text] [Related]
18. The roles of funding source, clinical trial outcome, and quality of reporting in orthopedic surgery literature.
Khan SN; Mermer MJ; Myers E; Sandhu HS
Am J Orthop (Belle Mead NJ); 2008 Dec; 37(12):E205-12; discussion E212. PubMed ID: 19212579
[TBL] [Abstract][Full Text] [Related]
19. Outcome reporting among drug trials registered in ClinicalTrials.gov.
Bourgeois FT; Murthy S; Mandl KD
Ann Intern Med; 2010 Aug; 153(3):158-66. PubMed ID: 20679560
[TBL] [Abstract][Full Text] [Related]
20. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]